Tumor necrosis factor (TNF) is a monokine potentially useful as a therapy for neoplastic disorders which also functions as a central mediator of the cachectic state and lethal effects of endotoxin in mice. Interaction of TNF with endothelium could provide a common denominator for the elicitation of responses in multiple organ systems, characteristic of the host response to inflammatory and neoplastic stimuli. This proposal is motivated by the hypothesis that endothelium is a primary target mediating the biologic effects of TNF and that TNF-induced perturbation of endothelium is critical for tumor necrosis. Preliminary data using cultured endothelium indicate that TNF does modulate endothelial cell coagulant properties, Interleukin-1 generation, proliferation and integrity of the monolayer providing powerful mechanisms for interrupting the blood supply to neoplastic lesions and inducing toxic effects in normal tissues. We seek to understand mechanisms underlying these changes in endothelial cell physiology induced by TNF and correlate them with in vivo findings following infusion of TNF into normal and tumor-bearing animals. A potentially important link between endothelial cell coagulation factor receptors and TNF-induced modulation of endothelial function will be explored: occupancy of endothelial cell activated protein C/protein S (APC/PS) sites decreases TNF binding to its receptor on endothelium and prevents several changes induced by TNF in cell surface coagulant properties. The ability of APC/PS to attenuate the endothelial cell response to TNF will be studied in the context of endothelial cell coagulant, growth and morphologic properties. Mechanisms involved in modulation of the cellular TNF response by APC/PS will be examined at the level of TNF-receptor interaction and second messenger pathways including cyclo-oxygenase metabolites and cytosolic calcium flux. The capacity of APC/PS to regulate the TNF response of two types of physiologically altered endothelium, Gamma-interferon-treated cells and preconfluent endothelium will be contrasted with confluent endothelial cells. If the contribution of APC/PS is different in these situations, this would suggest that occupancy of endothelial cell APC/PS sites may provide a mechanism for targeting TNF effects to the tumor vascular beds. This hypothesis will be tested in infusion studies in which TNF and APC/PS will be given to normal and tumor-bearing mice. Results of these studies should contribute to the understanding of mechanisms underlying TNF-endothelial cell interaction, thereby potentially optimizing TNF action in the tumor vascular bed, while minimizing effects in the surrounding tissues.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA043902-03
Application #
3186364
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1987-03-01
Project End
1990-02-28
Budget Start
1988-03-07
Budget End
1989-02-28
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Andersen, Jan Terje; Foss, Stian; Kenanova, Vania E et al. (2012) Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. J Biol Chem 287:22927-37
Stern, D M; Esposito, C; Gerlach, H et al. (1991) Endothelium and regulation of coagulation. Diabetes Care 14:160-6
Cozzolino, F; Torcia, M; Aldinucci, D et al. (1990) Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci U S A 87:6487-91
Clauss, M; Murray, J C; Vianna, M et al. (1990) A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem 265:7078-83
Gerlach, H; Esposito, C; Stern, D M (1990) Modulation of endothelial hemostatic properties: an active role in the host response. Annu Rev Med 41:15-24
Esposito, C; Gerlach, H; Brett, J et al. (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-407
Gerlach, H; Lieberman, H; Bach, R et al. (1989) Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med 170:913-31
Brett, J; Gerlach, H; Nawroth, P et al. (1989) Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 169:1977-91
May, L T; Torcia, G; Cozzolino, F et al. (1989) Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun 159:991-8
Nawroth, P; Handley, D; Matsueda, G et al. (1988) Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med 168:637-47

Showing the most recent 10 out of 12 publications